Global mRNA Vaccines & Therapeutics Market Growth 2023-2028

Report ID: 1319689 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global mRNA Vaccines & Therapeutics Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for mRNA Vaccines & Therapeutics by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for mRNA Vaccines & Therapeutics by Country/Region, 2017, 2022 & 2028
    2.2 mRNA Vaccines & Therapeutics Segment by Type
        2.2.1 Infectious Disease Vaccines
        2.2.2 Cancer Vaccines
    2.3 mRNA Vaccines & Therapeutics Sales by Type
        2.3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022)
        2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2017-2022)
        2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2017-2022)
    2.4 mRNA Vaccines & Therapeutics Segment by Application
        2.4.1 Infectious Disease
        2.4.2 Cancer
    2.5 mRNA Vaccines & Therapeutics Sales by Application
        2.5.1 Global mRNA Vaccines & Therapeutics Sale Market Share by Application (2017-2022)
        2.5.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Application (2017-2022)
        2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Application (2017-2022)
3 Global mRNA Vaccines & Therapeutics by Company
    3.1 Global mRNA Vaccines & Therapeutics Breakdown Data by Company
        3.1.1 Global mRNA Vaccines & Therapeutics Annual Sales by Company (2020-2022)
        3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2022)
    3.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Company (2020-2022)
        3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Company (2020-2022)
        3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2022)
    3.3 Global mRNA Vaccines & Therapeutics Sale Price by Company
    3.4 Key Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers mRNA Vaccines & Therapeutics Product Location Distribution
        3.4.2 Players mRNA Vaccines & Therapeutics Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for mRNA Vaccines & Therapeutics by Geographic Region
    4.1 World Historic mRNA Vaccines & Therapeutics Market Size by Geographic Region (2017-2022)
        4.1.1 Global mRNA Vaccines & Therapeutics Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Geographic Region
    4.2 World Historic mRNA Vaccines & Therapeutics Market Size by Country/Region (2017-2022)
        4.2.1 Global mRNA Vaccines & Therapeutics Annual Sales by Country/Region (2017-2022)
        4.2.2 Global mRNA Vaccines & Therapeutics Annual Revenue by Country/Region
    4.3 Americas mRNA Vaccines & Therapeutics Sales Growth
    4.4 APAC mRNA Vaccines & Therapeutics Sales Growth
    4.5 Europe mRNA Vaccines & Therapeutics Sales Growth
    4.6 Middle East & Africa mRNA Vaccines & Therapeutics Sales Growth
5 Americas
    5.1 Americas mRNA Vaccines & Therapeutics Sales by Country
        5.1.1 Americas mRNA Vaccines & Therapeutics Sales by Country (2017-2022)
        5.1.2 Americas mRNA Vaccines & Therapeutics Revenue by Country (2017-2022)
    5.2 Americas mRNA Vaccines & Therapeutics Sales by Type
    5.3 Americas mRNA Vaccines & Therapeutics Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC mRNA Vaccines & Therapeutics Sales by Region
        6.1.1 APAC mRNA Vaccines & Therapeutics Sales by Region (2017-2022)
        6.1.2 APAC mRNA Vaccines & Therapeutics Revenue by Region (2017-2022)
    6.2 APAC mRNA Vaccines & Therapeutics Sales by Type
    6.3 APAC mRNA Vaccines & Therapeutics Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe mRNA Vaccines & Therapeutics by Country
        7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2017-2022)
        7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2022)
    7.2 Europe mRNA Vaccines & Therapeutics Sales by Type
    7.3 Europe mRNA Vaccines & Therapeutics Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Country
        8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2017-2022)
        8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2017-2022)
    8.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type
    8.3 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of mRNA Vaccines & Therapeutics
    10.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
    10.4 Industry Chain Structure of mRNA Vaccines & Therapeutics
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 mRNA Vaccines & Therapeutics Distributors
    11.3 mRNA Vaccines & Therapeutics Customer
12 World Forecast Review for mRNA Vaccines & Therapeutics by Geographic Region
    12.1 Global mRNA Vaccines & Therapeutics Market Size Forecast by Region
        12.1.1 Global mRNA Vaccines & Therapeutics Forecast by Region (2023-2028)
        12.1.2 Global mRNA Vaccines & Therapeutics Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global mRNA Vaccines & Therapeutics Forecast by Type
    12.7 Global mRNA Vaccines & Therapeutics Forecast by Application
13 Key Players Analysis
    13.1 Moderna Therapeutics
        13.1.1 Moderna Therapeutics Company Information
        13.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered
        13.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Moderna Therapeutics Main Business Overview
        13.1.5 Moderna Therapeutics Latest Developments
    13.2 CureVac
        13.2.1 CureVac Company Information
        13.2.2 CureVac mRNA Vaccines & Therapeutics Product Offered
        13.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 CureVac Main Business Overview
        13.2.5 CureVac Latest Developments
    13.3 Translate Bio
        13.3.1 Translate Bio Company Information
        13.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Offered
        13.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Translate Bio Main Business Overview
        13.3.5 Translate Bio Latest Developments
    13.4 BioNTech
        13.4.1 BioNTech Company Information
        13.4.2 BioNTech mRNA Vaccines & Therapeutics Product Offered
        13.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 BioNTech Main Business Overview
        13.4.5 BioNTech Latest Developments
    13.5 Sangamo Therapeutics
        13.5.1 Sangamo Therapeutics Company Information
        13.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered
        13.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Sangamo Therapeutics Main Business Overview
        13.5.5 Sangamo Therapeutics Latest Developments
    13.6 Argos Therapeutics
        13.6.1 Argos Therapeutics Company Information
        13.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered
        13.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Argos Therapeutics Main Business Overview
        13.6.5 Argos Therapeutics Latest Developments
    13.7 In-Cell-Art
        13.7.1 In-Cell-Art Company Information
        13.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Offered
        13.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 In-Cell-Art Main Business Overview
        13.7.5 In-Cell-Art Latest Developments
    13.8 eTheRNA
        13.8.1 eTheRNA Company Information
        13.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Offered
        13.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 eTheRNA Main Business Overview
        13.8.5 eTheRNA Latest Developments
    13.9 Ethris
        13.9.1 Ethris Company Information
        13.9.2 Ethris mRNA Vaccines & Therapeutics Product Offered
        13.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Ethris Main Business Overview
        13.9.5 Ethris Latest Developments
    13.10 Tiba Biotechnology
        13.10.1 Tiba Biotechnology Company Information
        13.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered
        13.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Tiba Biotechnology Main Business Overview
        13.10.5 Tiba Biotechnology Latest Developments
14 Research Findings and Conclusion
List of Tables
    Table 1. mRNA Vaccines & Therapeutics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. mRNA Vaccines & Therapeutics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Infectious Disease Vaccines
    Table 4. Major Players of Cancer Vaccines
    Table 5. Global mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
    Table 6. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022)
    Table 7. Global mRNA Vaccines & Therapeutics Revenue by Type (2017-2022) & ($ million)
    Table 8. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2022)
    Table 9. Global mRNA Vaccines & Therapeutics Sale Price by Type (2017-2022) & (USD/Doses)
    Table 10. Global mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
    Table 11. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022)
    Table 12. Global mRNA Vaccines & Therapeutics Revenue by Application (2017-2022)
    Table 13. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2022)
    Table 14. Global mRNA Vaccines & Therapeutics Sale Price by Application (2017-2022) & (USD/Doses)
    Table 15. Global mRNA Vaccines & Therapeutics Sales by Company (2020-2022) & (M Doses)
    Table 16. Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2020-2022)
    Table 17. Global mRNA Vaccines & Therapeutics Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2020-2022)
    Table 19. Global mRNA Vaccines & Therapeutics Sale Price by Company (2020-2022) & (USD/Doses)
    Table 20. Key Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution and Sales Area
    Table 21. Players mRNA Vaccines & Therapeutics Products Offered
    Table 22. mRNA Vaccines & Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global mRNA Vaccines & Therapeutics Sales by Geographic Region (2017-2022) & (M Doses)
    Table 26. Global mRNA Vaccines & Therapeutics Sales Market Share Geographic Region (2017-2022)
    Table 27. Global mRNA Vaccines & Therapeutics Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global mRNA Vaccines & Therapeutics Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global mRNA Vaccines & Therapeutics Sales by Country/Region (2017-2022) & (M Doses)
    Table 30. Global mRNA Vaccines & Therapeutics Sales Market Share by Country/Region (2017-2022)
    Table 31. Global mRNA Vaccines & Therapeutics Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global mRNA Vaccines & Therapeutics Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses)
    Table 34. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country (2017-2022)
    Table 35. Americas mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country (2017-2022)
    Table 37. Americas mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
    Table 38. Americas mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022)
    Table 39. Americas mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
    Table 40. Americas mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022)
    Table 41. APAC mRNA Vaccines & Therapeutics Sales by Region (2017-2022) & (M Doses)
    Table 42. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region (2017-2022)
    Table 43. APAC mRNA Vaccines & Therapeutics Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Region (2017-2022)
    Table 45. APAC mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
    Table 46. APAC mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022)
    Table 47. APAC mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
    Table 48. APAC mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022)
    Table 49. Europe mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses)
    Table 50. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2017-2022)
    Table 51. Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2017-2022)
    Table 53. Europe mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
    Table 54. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022)
    Table 55. Europe mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
    Table 56. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2017-2022) & (M Doses)
    Table 58. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2017-2022) & (M Doses)
    Table 62. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2017-2022) & (M Doses)
    Table 64. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of mRNA Vaccines & Therapeutics
    Table 66. Key Market Challenges & Risks of mRNA Vaccines & Therapeutics
    Table 67. Key Industry Trends of mRNA Vaccines & Therapeutics
    Table 68. mRNA Vaccines & Therapeutics Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. mRNA Vaccines & Therapeutics Distributors List
    Table 71. mRNA Vaccines & Therapeutics Customer List
    Table 72. Global mRNA Vaccines & Therapeutics Sales Forecast by Region (2023-2028) & (M Doses)
    Table 73. Global mRNA Vaccines & Therapeutics Sales Market Forecast by Region
    Table 74. Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas mRNA Vaccines & Therapeutics Sales Forecast by Country (2023-2028) & (M Doses)
    Table 77. Americas mRNA Vaccines & Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC mRNA Vaccines & Therapeutics Sales Forecast by Region (2023-2028) & (M Doses)
    Table 79. APAC mRNA Vaccines & Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe mRNA Vaccines & Therapeutics Sales Forecast by Country (2023-2028) & (M Doses)
    Table 81. Europe mRNA Vaccines & Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa mRNA Vaccines & Therapeutics Sales Forecast by Country (2023-2028) & (M Doses)
    Table 83. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2023-2028) & (M Doses)
    Table 85. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2023-2028) & (M Doses)
    Table 89. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Moderna Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
    Table 93. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered
    Table 94. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 95. Moderna Therapeutics Main Business
    Table 96. Moderna Therapeutics Latest Developments
    Table 97. CureVac Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
    Table 98. CureVac mRNA Vaccines & Therapeutics Product Offered
    Table 99. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 100. CureVac Main Business
    Table 101. CureVac Latest Developments
    Table 102. Translate Bio Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
    Table 103. Translate Bio mRNA Vaccines & Therapeutics Product Offered
    Table 104. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 105. Translate Bio Main Business
    Table 106. Translate Bio Latest Developments
    Table 107. BioNTech Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
    Table 108. BioNTech mRNA Vaccines & Therapeutics Product Offered
    Table 109. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 110. BioNTech Main Business
    Table 111. BioNTech Latest Developments
    Table 112. Sangamo Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
    Table 113. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered
    Table 114. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 115. Sangamo Therapeutics Main Business
    Table 116. Sangamo Therapeutics Latest Developments
    Table 117. Argos Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
    Table 118. Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered
    Table 119. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 120. Argos Therapeutics Main Business
    Table 121. Argos Therapeutics Latest Developments
    Table 122. In-Cell-Art Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
    Table 123. In-Cell-Art mRNA Vaccines & Therapeutics Product Offered
    Table 124. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 125. In-Cell-Art Main Business
    Table 126. In-Cell-Art Latest Developments
    Table 127. eTheRNA Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
    Table 128. eTheRNA mRNA Vaccines & Therapeutics Product Offered
    Table 129. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 130. eTheRNA Main Business
    Table 131. eTheRNA Latest Developments
    Table 132. Ethris Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
    Table 133. Ethris mRNA Vaccines & Therapeutics Product Offered
    Table 134. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 135. Ethris Main Business
    Table 136. Ethris Latest Developments
    Table 137. Tiba Biotechnology Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
    Table 138. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered
    Table 139. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 140. Tiba Biotechnology Main Business
    Table 141. Tiba Biotechnology Latest Developments
List of Figures
    Figure 1. Picture of mRNA Vaccines & Therapeutics
    Figure 2. mRNA Vaccines & Therapeutics Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global mRNA Vaccines & Therapeutics Sales Growth Rate 2017-2028 (M Doses)
    Figure 7. Global mRNA Vaccines & Therapeutics Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. mRNA Vaccines & Therapeutics Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Infectious Disease Vaccines
    Figure 10. Product Picture of Cancer Vaccines
    Figure 11. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2021
    Figure 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2022)
    Figure 13. mRNA Vaccines & Therapeutics Consumed in Infectious Disease
    Figure 14. Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2017-2022) & (M Doses)
    Figure 15. mRNA Vaccines & Therapeutics Consumed in Cancer
    Figure 16. Global mRNA Vaccines & Therapeutics Market: Cancer (2017-2022) & (M Doses)
    Figure 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2022)
    Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application in 2021
    Figure 19. mRNA Vaccines & Therapeutics Revenue Market by Company in 2021 ($ Million)
    Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company in 2021
    Figure 21. Global mRNA Vaccines & Therapeutics Sales Market Share by Geographic Region (2017-2022)
    Figure 22. Global mRNA Vaccines & Therapeutics Revenue Market Share by Geographic Region in 2021
    Figure 23. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2017-2022)
    Figure 24. Global mRNA Vaccines & Therapeutics Revenue Market Share by Country/Region in 2021
    Figure 25. Americas mRNA Vaccines & Therapeutics Sales 2017-2022 (M Doses)
    Figure 26. Americas mRNA Vaccines & Therapeutics Revenue 2017-2022 ($ Millions)
    Figure 27. APAC mRNA Vaccines & Therapeutics Sales 2017-2022 (M Doses)
    Figure 28. APAC mRNA Vaccines & Therapeutics Revenue 2017-2022 ($ Millions)
    Figure 29. Europe mRNA Vaccines & Therapeutics Sales 2017-2022 (M Doses)
    Figure 30. Europe mRNA Vaccines & Therapeutics Revenue 2017-2022 ($ Millions)
    Figure 31. Middle East & Africa mRNA Vaccines & Therapeutics Sales 2017-2022 (M Doses)
    Figure 32. Middle East & Africa mRNA Vaccines & Therapeutics Revenue 2017-2022 ($ Millions)
    Figure 33. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country in 2021
    Figure 34. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2021
    Figure 35. United States mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 36. Canada mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Mexico mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Brazil mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 39. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region in 2021
    Figure 40. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2021
    Figure 41. China mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Japan mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 43. South Korea mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Southeast Asia mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 45. India mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Australia mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country in 2021
    Figure 48. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2021
    Figure 49. Germany mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 50. France mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 51. UK mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Italy mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Russia mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country in 2021
    Figure 55. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2021
    Figure 56. Egypt mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 57. South Africa mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Israel mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Turkey mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 60. GCC Country mRNA Vaccines & Therapeutics Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Manufacturing Cost Structure Analysis of mRNA Vaccines & Therapeutics in 2021
    Figure 62. Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
    Figure 63. Industry Chain Structure of mRNA Vaccines & Therapeutics
    Figure 64. Channels of Distribution
    Figure 65. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global mRNA Vaccines & Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global mRNA Vaccines & Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global mRNA Vaccines & Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports